These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1385878)

  • 1. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice.
    Skrinskaya JA; Nikulina EM; Popova NK
    Pharmacol Biochem Behav; 1992 Jun; 42(2):261-7. PubMed ID: 1385878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genotypic differences in the metabolism of brain dopamine and in the dopamine-dependent forms of behavior in mice].
    Skrinskaia IuA; Nikulina EM
    Genetika; 1988 Jul; 24(7):1321-4. PubMed ID: 3181756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of deprenil on the dopaminergic system of the brain in mice of different genotypes during aging].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(4-5):842-8. PubMed ID: 7810226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic brain system in the quaking mutant mouse.
    Nikulina EM; Skrinskaya JA; Avgustinovich DF; Popova NK
    Pharmacol Biochem Behav; 1995 Mar; 50(3):333-7. PubMed ID: 7617670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor.
    Fetsko LA; Xu R; Wang Y
    Brain Res; 2003 Mar; 967(1-2):191-200. PubMed ID: 12650980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic influences on striatal dopaminergic regulation in mice.
    Severson JA; Randall PK; Finch CE
    Brain Res; 1981 Apr; 210(1-2):201-15. PubMed ID: 6261873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC; Altar CA
    J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine receptors in the regulation of aggression in mice; relationship to genotype.
    Nikulina EM; Kapralova NS
    Neurosci Behav Physiol; 1992; 22(5):364-9. PubMed ID: 1359448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
    Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency and efficacy of dopamine agonists in mouse strains differing in dopamine cell and receptor number.
    Shannon HE; Bemis KG; Peters SC
    Pharmacol Biochem Behav; 1991 Sep; 40(1):103-7. PubMed ID: 1685781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors.
    Seale TW; McLanahan K; Johnson P; Carney JM; Rennert OM
    Pharmacol Biochem Behav; 1984 Aug; 21(2):237-44. PubMed ID: 6541342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P; Charpentier S; Costentin J
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
    Foreman MM; Fuller RW; Hynes MD; Gidda JS; Nichols CL; Schaus JM; Kornfeld EC; Clemens JA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):227-35. PubMed ID: 2526214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in clonidine-induced aggressiveness in mice and its interaction with the dopamine system.
    Nikulina EM; Klimek V
    Pharmacol Biochem Behav; 1993 Apr; 44(4):821-5. PubMed ID: 8097040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.